Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1

Conditions

Rectal Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Familial primary gastric lymphoma 1Colorectal Neoplasms 1

Interventions

Rituximab 23Cyclophosphamide 11Radiotherapy 8Prednisone 8Vincristine 7Doxorubicin 7Lenalidomide 6Bendamustine Hydrochloride 5Chlorambucil 4Peripheral Blood Stem Cell Transplantation 3Filgrastim 3obinutuzumab 2liposomal amphotericin B 2idelalisib 2ibrutinib 2fludarabine phosphate 2VAP-cyclo protocol 2Therapeutics 2Psychiatric Rehabilitation 2Levofloxacin 2Interferon-alpha 2Idarubicin 2Epoetin Alfa 2Early Intervention, Educational 2Cyclosporine 2Busulfan 2zanubrutinib 1tafasitamab 1parsaclisib 1orelabrutinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, B-Cell, Marginal Zone × Metronidazole × Clear all
NCT00154440 2007-03-26

Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation

Technische Universität Dresden

Phase 3 Unknown
200 enrolled
GastrointestinalLymphoid

Familial primary gastric lymphoma, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡